NASDAQ:GBT - Global Blood Therapeutics, Inc.
$56.23
 $0.67
+1.21%
12:00PM EDT
2019-07-22
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD). The Company is evaluating GBT440 in SCD in a Phase III clinical trial of GBT440 in adult and adolescent patients with SCD. GBT440 inhibits abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. The Company is also engaged in other research and development activities targeted towards hereditary angioedema (HAE). The Company's GBT440 is an investigational drug that increases hemoglobin's affinity for oxygen by binding to the alpha-chain of hemoglobin. GBT440 has been observed to keep a proportion of sickle hemoglobin (HbS), in its oxygenated state, where it cannot participate in polymerization. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  GBT     avg for
industry  
  avg for
sector  
42 stocks weight:  145. 41   217. 37   399. 45  
42 stocks rank:  1. 43 K 1. 27 K 716. 99  
# analyst opinions:  13. 00   13. 21   13. 71  
mean recommendation:  1. 70   2. 10   2. 04  

quick ratio:  14. 25   5. 49   1. 88  
current ratio:  14. 51   5. 87   2. 36  

target price low:  61. 00   83. 44   114. 90  
target price avg:  92. 00   106. 20   137. 90  
target price high:  150. 00   132. 30   158. 97  
1-yr high:  63. 29   111. 86   142. 57  
last close:  55. 56   86. 79   125. 44  
50-day avg:  57. 59   86. 68   122. 63  
200-day avg:  48. 62   89. 22   121. 38  
1-yr low:  31. 54   69. 78   100. 51  
volume:  426. 18 K 2. 62 M 3. 43 M
50-day avg volume:  1. 01 M 3. 20 M 4. 16 M
200-day avg volume:  963. 38 K 2. 99 M 4. 75 M

1-day return:  -3. 36 % -1. 30 % -0. 99 %
this week return:  -2. 61 % 0. 45 % -0. 20 %
12-wk return:  -1. 75 % 0. 94 % 4. 84 %
52-wk return:  36. 56 % -1. 30 % 10. 55 %

enterprise value (EV):  2. 70 B 45. 10 B 122. 38 B
market cap:  3. 32 B 38. 96 B 108. 40 B
EBITDA:  -190. 54 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -14. 18   5. 38   11. 93  
total debt:  25. 65 M 10. 90 B 17. 48 B
debt/equity:  4. 61   57. 18   120. 05  
net income (common):  -181. 56 M 2. 07 B 4. 05 B

shares outstanding:  0. 00   538. 09 M 1. 24 B
shares:  49. 64 M 548. 00 M 1. 22 B
shares short:  7. 72 M 10. 98 M 11. 87 M
shares short prior month:  7. 68 M 9. 32 M 12. 05 M
short ratio:  5. 58   5. 60   3. 34  
short % of float:  16. 60 % 6. 48 % 2. 64 %
total cash/share:  8. 11   10. 98   9. 19  
total cash:  457. 27 M 5. 93 B 6. 10 B
free cash flow:  -81. 93 M 2. 92 B 4. 55 B
operating cash flow:  -138. 92 M 3. 80 B 5. 78 B

book value:  9. 88   13. 35   27. 45  
price/book:  5. 62   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -3. 41   2. 10   4. 23  
forward EPS:  -3. 37   3. 45   7. 10  
P/E:  -16. 30   1. 90   32. 10  
forward P/E:  -16. 49   6. 46   15. 47  
PE/G:  3. 36   0. 70   -0. 54  
growth:  -4. 85 % 265. 63 % 79. 11 %
earnings high:  -0. 87   0. 89   1. 68  
earnings avg:  -0. 96   0. 70   1. 57  
earnings low:  -1. 07   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -20. 29 % -2. 34 % 5. 28 %
return on equity:  -33. 18 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  1. 91   1. 27   0. 91  
sharpe (1yr):  0. 74   0. 16   0. 77  

held % insiders:  62. 29 % 6. 06 % 3. 29 %
held % institutions:  13. 19 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : GBT
.    145.526 =       145.526 :: --> INITIAL WEIGHT <--
.    - 3.409 =       142.117 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.412 =       342.757 :: P/E factor
.    x 0.905 =       310.188 :: PE/G factor
.    x 1.564 =       485.071 :: beta factor
.    x 0.904 =       438.499 :: sharpe factor
.    x 2.472 =      1083.922 :: current ratio factor
.    x 1.037 =      1124.084 :: quick ratio factor
.    x 1.086 =       1220.66 :: short ratio factor
.    x 1.069 =      1304.681 :: price-to-book factor
.     x 1.04 =      1356.243 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =       2876.31 :: sector+industry 1-year gains factor
.    x 1.009 =      2903.428 :: industry 12-weeks return factor
.    x 1.308 =       3797.36 :: industry 2-weeks return factor
.    x 1.344 =       5102.33 :: company one-year gains+dividend factor
.    x 3.241 =     16536.892 :: company 13 weeks' performance factor
.    x 1.329 =     21982.562 :: 5-day avg > 200-day avg
.    x 1.184 =     26036.802 :: 50-day avg > 200-day avg
.    x 0.976 =     25418.695 :: "drift" penalty 2 days ago
.    x 0.978 =     24864.052 :: "drift" penalty 5 days ago
.    / 1.973 =      12602.55 :: overall "drift" factor
.    x 0.756 =      9528.282 :: largest single-day jump factor
.        x 1 =      9528.282 :: volatility factor
.        x 1 =      9528.282 :: 42-day volatility factor
.    x 5.117 =     48759.859 :: notable returns + performance factor
.    x 3.023 =    147394.723 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.679 =      100122.6 :: forward EPS factor
.    x 0.883 =     88454.059 :: forward P/E factor
.    x 1.185 =    104792.629 :: industry recommendation factor
.    x 2.934 =    307415.392 :: company recommendation factor
.    x 1.003 =    308265.514 :: factor historical industry gain for week 29
.    x 1.388 =    427944.045 :: target low factor
.     x 1.27 =    543468.466 :: target mean factor
.    x 1.055 =    573227.615 :: target high factor
.   x 11.022 =   6317871.778 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        50.135 :: reduced for readability
.   + 91.697 =       141.832 :: add/subtract for investor sentiment
.    + 3.575 =       145.407 :: earnings report in 10 days
.                               --> FINAL WEIGHT <--
.                    145.407 :: FINAL WEIGHT for NASDAQ:GBT


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org